If you are:
Only When Necessary: INSUFFICIENT HUMAN DATA;MICE DATA SUGG DEVELOPMENTAL TOCIXITY AT 3.6-7.9 X MRHD
Precaution: INSUFFICIENT HUMAN DATA AVAILABLE; EXCRETED IN RAT STUDIES
An adult over 60:
management or monitoring precaution: Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. High risk of delirium Gastrointestinal-May cause or worsen pre-existing constipation. Urogenital-Best avoided in patients with urinary retention from any cause. Renal-Maximum dose of 5 mg/day for CrCL < 30 mL/min. Ocular-Use cautiously if being treated for narrow-angle glaucoma. Cardiovascular-Risk of QT prolongation and atrial fibrillation may occur.
Giving Vesicare to a child under 12:
management or monitoring precaution: Safety and efficacy not established.